CRISPR
The five-year grant will support the development of a palm-sized instrument and test strips that could provide results within the first weeks following infections.
The assays can be used to detect influenza A and influenza B, distinguish between flu subtypes, and identify strains that are resistant to antiviral treatment.
Top Five Articles on 360Dx Last Week: Biocept Bankruptcy; 3EO Health NIH Grant; More
Last week, readers were most interested in a story about Biocept's Chapter 7 bankruptcy filing.
The firm claims to have developed a technology that enables one-minute nucleic acid detection at room temperature without the need for target amplification.
CRISPR Molecular Detection Startup VedaBio Secures $40M in Series A Financing
The San Diego-based company uses a proprietary method called CRISPR Cascade for room-temperature detection of nucleic acids in one minute without the need for target amplification.